Urinary bladder relaxation through activation of imidazoline receptors induced by agmatine is increased in diabetic rats

Tsung Chin Tsai, Chia Ho Lin, Hsien Hui Chung, Juei Tang Cheng, I. Hung Chen, Yat Ching Tong

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objectives: The effect of agmatine on bladder contractility and the diabetes-induced alteration of this action were studied in the rat. Methods: Bladder strips were isolated from 9-week-old streptozotocin (STZ)-diabetic rats and control Wistar rats. Strips were hung in an organ bath for measurement of isometric tension and pre-contracted with either 1μmol/L acetylcholine (ACh) or 50mmol/L KCl. Dose-dependent relaxation of the bladder strips was studied by cumulative administration of agmatine 1-100μmol/L into the organ bath. Effects of specific imidazoline receptor (IR) antagonists on the agmatine-induced relaxation were studied. Western blotting analysis was used to measure bladder IR, sulphonylurea receptor (SUR) and inwardly rectifying K+ channel subunit 6.2 (Kir 6.2) protein levels. Results: Agmatine reduced ACh and KCl pre-contracted bladder strip tension in a dose-dependent fashion. Relaxation was significantly increased in STZ-diabetic rats. The relaxation was inhibited by BU224, a selective I2 IR antagonist; but not by efaroxan (I1 IR antagonist) or KU14R (I3 IR antagonist). Moreover, the agmatine-induced relaxation was attenuated by glibenclamide (inhibitor of KATP channel) and H-89 (inhibitor of protein kinase A), but enhanced by 3-isobutyl-1-methylxanthine (IBMX, inhibitor of cyclic AMP phosphodiesterase). Western blotting showed increased expression of bladder IR but not SUR or Kir 6.2 in the STZ-diabetic rat. Conclusion: Agmatine causes rat bladder relaxation by activation of the I2 IR, which opens KATP channels through the cyclic AMP/protein kinase A pathway. Agmatine-induced bladder relaxation in STZ-diabetic rats is increased due to a higher expression of IR.

Original languageEnglish
Pages (from-to)117-123
Number of pages7
JournalLUTS: Lower Urinary Tract Symptoms
Volume6
Issue number2
DOIs
Publication statusPublished - 2014 Jan 1

Fingerprint

Imidazoline Receptors
Agmatine
Urinary Bladder
Streptozocin
Sulfonylurea Receptors
1-Methyl-3-isobutylxanthine
KATP Channels
efaroxan
Cyclic AMP-Dependent Protein Kinases
Baths
Cyclic AMP
Acetylcholine
Western Blotting
Inwardly Rectifying Potassium Channel
Adenylate Kinase
Glyburide
Phosphoric Diester Hydrolases
Wistar Rats

All Science Journal Classification (ASJC) codes

  • Neurology
  • Urology

Cite this

@article{53ed741259d6478db1b73d7c0c8bb5aa,
title = "Urinary bladder relaxation through activation of imidazoline receptors induced by agmatine is increased in diabetic rats",
abstract = "Objectives: The effect of agmatine on bladder contractility and the diabetes-induced alteration of this action were studied in the rat. Methods: Bladder strips were isolated from 9-week-old streptozotocin (STZ)-diabetic rats and control Wistar rats. Strips were hung in an organ bath for measurement of isometric tension and pre-contracted with either 1μmol/L acetylcholine (ACh) or 50mmol/L KCl. Dose-dependent relaxation of the bladder strips was studied by cumulative administration of agmatine 1-100μmol/L into the organ bath. Effects of specific imidazoline receptor (IR) antagonists on the agmatine-induced relaxation were studied. Western blotting analysis was used to measure bladder IR, sulphonylurea receptor (SUR) and inwardly rectifying K+ channel subunit 6.2 (Kir 6.2) protein levels. Results: Agmatine reduced ACh and KCl pre-contracted bladder strip tension in a dose-dependent fashion. Relaxation was significantly increased in STZ-diabetic rats. The relaxation was inhibited by BU224, a selective I2 IR antagonist; but not by efaroxan (I1 IR antagonist) or KU14R (I3 IR antagonist). Moreover, the agmatine-induced relaxation was attenuated by glibenclamide (inhibitor of KATP channel) and H-89 (inhibitor of protein kinase A), but enhanced by 3-isobutyl-1-methylxanthine (IBMX, inhibitor of cyclic AMP phosphodiesterase). Western blotting showed increased expression of bladder IR but not SUR or Kir 6.2 in the STZ-diabetic rat. Conclusion: Agmatine causes rat bladder relaxation by activation of the I2 IR, which opens KATP channels through the cyclic AMP/protein kinase A pathway. Agmatine-induced bladder relaxation in STZ-diabetic rats is increased due to a higher expression of IR.",
author = "Tsai, {Tsung Chin} and Lin, {Chia Ho} and Chung, {Hsien Hui} and Cheng, {Juei Tang} and Chen, {I. Hung} and Tong, {Yat Ching}",
year = "2014",
month = "1",
day = "1",
doi = "10.1111/luts.12031",
language = "English",
volume = "6",
pages = "117--123",
journal = "LUTS: Lower Urinary Tract Symptoms",
issn = "1757-5664",
publisher = "Wiley Blackwell",
number = "2",

}

Urinary bladder relaxation through activation of imidazoline receptors induced by agmatine is increased in diabetic rats. / Tsai, Tsung Chin; Lin, Chia Ho; Chung, Hsien Hui; Cheng, Juei Tang; Chen, I. Hung; Tong, Yat Ching.

In: LUTS: Lower Urinary Tract Symptoms, Vol. 6, No. 2, 01.01.2014, p. 117-123.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Urinary bladder relaxation through activation of imidazoline receptors induced by agmatine is increased in diabetic rats

AU - Tsai, Tsung Chin

AU - Lin, Chia Ho

AU - Chung, Hsien Hui

AU - Cheng, Juei Tang

AU - Chen, I. Hung

AU - Tong, Yat Ching

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Objectives: The effect of agmatine on bladder contractility and the diabetes-induced alteration of this action were studied in the rat. Methods: Bladder strips were isolated from 9-week-old streptozotocin (STZ)-diabetic rats and control Wistar rats. Strips were hung in an organ bath for measurement of isometric tension and pre-contracted with either 1μmol/L acetylcholine (ACh) or 50mmol/L KCl. Dose-dependent relaxation of the bladder strips was studied by cumulative administration of agmatine 1-100μmol/L into the organ bath. Effects of specific imidazoline receptor (IR) antagonists on the agmatine-induced relaxation were studied. Western blotting analysis was used to measure bladder IR, sulphonylurea receptor (SUR) and inwardly rectifying K+ channel subunit 6.2 (Kir 6.2) protein levels. Results: Agmatine reduced ACh and KCl pre-contracted bladder strip tension in a dose-dependent fashion. Relaxation was significantly increased in STZ-diabetic rats. The relaxation was inhibited by BU224, a selective I2 IR antagonist; but not by efaroxan (I1 IR antagonist) or KU14R (I3 IR antagonist). Moreover, the agmatine-induced relaxation was attenuated by glibenclamide (inhibitor of KATP channel) and H-89 (inhibitor of protein kinase A), but enhanced by 3-isobutyl-1-methylxanthine (IBMX, inhibitor of cyclic AMP phosphodiesterase). Western blotting showed increased expression of bladder IR but not SUR or Kir 6.2 in the STZ-diabetic rat. Conclusion: Agmatine causes rat bladder relaxation by activation of the I2 IR, which opens KATP channels through the cyclic AMP/protein kinase A pathway. Agmatine-induced bladder relaxation in STZ-diabetic rats is increased due to a higher expression of IR.

AB - Objectives: The effect of agmatine on bladder contractility and the diabetes-induced alteration of this action were studied in the rat. Methods: Bladder strips were isolated from 9-week-old streptozotocin (STZ)-diabetic rats and control Wistar rats. Strips were hung in an organ bath for measurement of isometric tension and pre-contracted with either 1μmol/L acetylcholine (ACh) or 50mmol/L KCl. Dose-dependent relaxation of the bladder strips was studied by cumulative administration of agmatine 1-100μmol/L into the organ bath. Effects of specific imidazoline receptor (IR) antagonists on the agmatine-induced relaxation were studied. Western blotting analysis was used to measure bladder IR, sulphonylurea receptor (SUR) and inwardly rectifying K+ channel subunit 6.2 (Kir 6.2) protein levels. Results: Agmatine reduced ACh and KCl pre-contracted bladder strip tension in a dose-dependent fashion. Relaxation was significantly increased in STZ-diabetic rats. The relaxation was inhibited by BU224, a selective I2 IR antagonist; but not by efaroxan (I1 IR antagonist) or KU14R (I3 IR antagonist). Moreover, the agmatine-induced relaxation was attenuated by glibenclamide (inhibitor of KATP channel) and H-89 (inhibitor of protein kinase A), but enhanced by 3-isobutyl-1-methylxanthine (IBMX, inhibitor of cyclic AMP phosphodiesterase). Western blotting showed increased expression of bladder IR but not SUR or Kir 6.2 in the STZ-diabetic rat. Conclusion: Agmatine causes rat bladder relaxation by activation of the I2 IR, which opens KATP channels through the cyclic AMP/protein kinase A pathway. Agmatine-induced bladder relaxation in STZ-diabetic rats is increased due to a higher expression of IR.

UR - http://www.scopus.com/inward/record.url?scp=84898047805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84898047805&partnerID=8YFLogxK

U2 - 10.1111/luts.12031

DO - 10.1111/luts.12031

M3 - Article

AN - SCOPUS:84898047805

VL - 6

SP - 117

EP - 123

JO - LUTS: Lower Urinary Tract Symptoms

JF - LUTS: Lower Urinary Tract Symptoms

SN - 1757-5664

IS - 2

ER -